Product Images Topiramate
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 4 images provide visual information about the product associated with Topiramate NDC 50090-3926 by A-s Medication Solutions, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
7ea951b6 b020 481f 8acc 12fb7a3a69fd 01
7ea951b6 b020 481f 8acc 12fb7a3a69fd 02
This is a graph that displays the cumulative rates for time to the first seizure for two groups of individuals. The first group of 234 individuals took 50mg/day of Topiramate, while the second group of 236 individuals took 400mg/day of Topiramate. The graph shows that the group taking 400mg/day had a significantly lower cumulative rate for time to the first seizure compared to the group taking 50mg/day, as represented by the p-value of 0.0002. The x-axis of the graph represents time in days, ranging from 0 to 400 days, while the y-axis shows the cumulative rate of individuals experiencing a first seizure, with values ranging from 0 to 100 percent.*
7ea951b6 b020 481f 8acc 12fb7a3a69fd 03
The text represents a table with data related to the effectiveness of different doses of topiramate in reducing the number of monthly migraine periods compared to a placebo, observed during a double-blind phase of two studies (numbered 11 and 12). However, the complete data is not available since the is not able to distinguish the values of the Average Monthly Migraine Period Rate, which are represented by placeholders.*
Label Image - lbl500903926
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.